Results 271 to 280 of about 52,382 (294)

Oncogenes in the myelodysplastic syndrome

Blood Reviews, 1989
The conversion of normal haemopoietic stem cells to myelodysplastic and then to leukaemic cells is marked by a number of events leading to progressive genetic changes in the abnormal clonal population. Cytogenetic evidence points to abnormalities at specific chromosomal locations, commonly involving chromosomes 5 and 7, where there are a particular ...
openaire   +2 more sources

Myelodysplastic Syndromes

Scottish Medical Journal, 1994
P G, Cachia, R A, Padua
openaire   +2 more sources

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆

Annals of Oncology, 2021
exaly  

Therapy with azanucleosides for myelodysplastic syndromes

Nature Reviews Clinical Oncology, 2010
Guillermo Garcia-Manero
exaly  

Decitabine in the treatment of myelodysplastic syndromes

Expert Review of Anticancer Therapy, 2010
Hagop M Kantarjian, Guillermo Garcia-Manero, Jean-Pierre J Issa   +2 more
exaly  

The myelodysplastic syndrome

European Journal of Cancer and Clinical Oncology, 1990
openaire   +2 more sources

Telomere length in myelodysplastic syndromes

Leukemia and Lymphoma, 2011
Dana E Rollison, Rami S Komrokji, Alan F List   +2 more
exaly  

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

Nature Genetics, 2010
Peter A Vandenberghe, Saskia Langemeijer, Joop H Jansen   +2 more
exaly  

Azacitidine in the management of patients with myelodysplastic syndromes

Therapeutic Advances in Hematology, 2012
John Lister
exaly  

The role of decitabine in the treatment of myelodysplastic syndromes

Expert Opinion on Pharmacotherapy, 2007
Ehab Atallah, Hagop M Kantarjian, Guillermo Garcia-Manero   +2 more
exaly